Font:
GL

GLENMARK / NSE / Biotechnology & Drugs

Glenmark Pharmaceuticals

INR 2,166.2-7.60 (-0.68%) 1D
Last updated: 2026-06-15T21:38:07.026206+00:00
Price Chart

1Y Price Trend

Open1,683.8
High2,474
Low1,625
Close2,156.6
Volume6,40,588
Change472.8
Change %28.08%

Key Information

Ticker SymbolGLENMARK
Current Price2,166.2
52-Week High2,474
52-Week Low1,512.8
Market Cap61,356.17
Beta0.61
Volume6,40,588
ISININE935A01035
Day High2,188
Day Low2,145.6
Open2,186

Recommendations

RatingStrong Buy

Target High2,471.05

Target Low1,448.5

Target Mean1.78

Target Median97.22

Risk Metrics

Overall RiskBalanced risk

Board Risk31.38

Key Analysis

Overall score, performance score, return rating, defensive, aggressive, and balanced views.

Download app

Projection Analytics

Best-case, base-case, worst-case, and dynamic AI projection views.

Download app
News

Latest stock news

Glenmark Consolidated March 2026 Net Sales at Rs 3,770.59 crore, up 15.8% Y-o-Y - Moneycontrol.com16 days ago
Market news

Glenmark Consolidated March 2026 Net Sales at Rs 3,770.59 crore, up 15.8% Y-o-Y Moneycontrol.com

Number of shareholders of Glenmark Pharmaceuticals Limited – NSE:GLENMARK - TradingView16 days ago
Market news

Number of shareholders of Glenmark Pharmaceuticals Limited – NSE:GLENMARK TradingView

Glenmark Pharmaceuticals Ltd. is Rated Strong Buy - Markets Mojo17 days ago
Market news

Glenmark Pharmaceuticals Ltd. is Rated Strong Buy Markets Mojo

Glenmark Pharmaceuticals Q4 FY26: Exceptional Quarter Marred by Sequential Decline - Markets Mojo17 days ago
Market news

Glenmark Pharmaceuticals Q4 FY26: Exceptional Quarter Marred by Sequential Decline Markets Mojo

Glenmark Pharmaceuticals appoints Ajay Jajoo as Group VP & Global Corporate Controller - Exchange4Media17 days ago
Market news

Glenmark Pharmaceuticals appoints Ajay Jajoo as Group VP & Global Corporate Controller Exchange4Media

Glenmark Pharma targets ₹18,000 crore revenue by FY27 on broad-based global growth - CNBC TV1817 days ago
Market news

Glenmark Pharma targets ₹18,000 crore revenue by FY27 on broad-based global growth CNBC TV18

Buy Glenmark Pharma; target of Rs 2610: Motilal Oswal - Moneycontrol.com17 days ago
Market news

Buy Glenmark Pharma; target of Rs 2610: Motilal Oswal Moneycontrol.com

Glenmark Pharmaceuticals Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals - Markets Mojo17 days ago
Market news

Glenmark Pharmaceuticals Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals Markets Mojo

FAQ

Stock FAQs

What is the NSE symbol for Glenmark Pharmaceuticals?

Glenmark Pharmaceuticals trades on NSE with the symbol GLENMARK. ShareKeyX uses the stock symbol in the public URL and keeps ISIN only for internal data matching and structured data.

Where can I track Glenmark Pharmaceuticals share price and chart?

You can track Glenmark Pharmaceuticals share price, OHLC chart, key information, ratios, financials, company information and news on this ShareKeyX market page.

Does ShareKeyX show financial data for Glenmark Pharmaceuticals?

Yes. ShareKeyX displays available financial statements for Glenmark Pharmaceuticals using the current Supabase company financial payload. Statement values are shown in INR crore.

Does ShareKeyX show historical OHLC data for Glenmark Pharmaceuticals?

Yes. ShareKeyX displays available historical OHLC candles for Glenmark Pharmaceuticals across supported chart ranges such as 7D, 1M, 3M, 6M and 1Y.

What sector or industry does Glenmark Pharmaceuticals belong to?

Glenmark Pharmaceuticals is classified under Biotechnology & Drugs in the available company data.

Does ShareKeyX show news for Glenmark Pharmaceuticals?

Yes. ShareKeyX shows the latest available stock news for Glenmark Pharmaceuticals from the connected stock news source.